Delta-Aminolevulinic Acid Dehydratase (ALAD) Antibody
312€ (60 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Delta-Aminolevulinic Acid Dehydratase (ALAD) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx005824
tested applications
IF/ICC
Description
ALAD Antibody is a Rabbit Polyclonal Antibody against ALAD.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Delta-Aminolevulinic Acid Dehydratase (ALAD) |
| Host | Rabbit |
| Reactivity | Human, Mouse |
| Recommended Dilution | IF/ICC: 1/50 - 1/200. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purification | Purified by affinity chromatography. |
| Size 1 | 60 µl |
| Size 2 | 120 µl |
| Size 3 | 200 µl |
| Form | Liquid |
| Tested Applications | IF/ICC |
| Buffer | PBS, pH 7.3, containing 0.02% sodium azide, 50% glycerol. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | P13716 |
| Gene ID | 210 |
| NCBI Accession | NP_000022.3 |
| Alias | ALADH,Porphobilinogen synthase,ALA dehydratase |
| Background | Antibody anti-ALAD |
| Status | RUO |
| Note | Concentration: 1 mg/ml - |
Descripción
Aminolevulinate Delta Dehydratase (ALAD) is a key enzyme in the heme biosynthesis pathway, catalyzing the condensation of two molecules of aminolevulinic acid (ALA) into porphobilinogen (PBG), a precursor to heme. ALAD is predominantly expressed in the liver and bone marrow, where heme production is critical for hemoglobin synthesis in red blood cells and for cytochrome function in metabolic processes. The enzyme requires zinc as a cofactor for its activity, and mutations or environmental inhibitors, such as lead, can impair ALAD function, leading to disorders such as porphyria or anemia. Lead poisoning inhibits ALAD by displacing zinc, resulting in the accumulation of ALA and associated neurotoxic effects. ALAD mutations can also cause ALAD porphyria, a rare genetic disorder marked by abdominal pain, neuropsychiatric symptoms, and photosensitivity. ALAD is a target of interest for understanding and mitigating lead toxicity and heme-related metabolic disorders.
Related Products
Human ALAD (Delta-aminolevulinic acid dehydRatase) ELISA Kit
Ver Producto
Mouse ALAD (Aminolevulinate Delta DehydRatase) ELISA Kit
Ver Producto